Scaling Up Production
Transforming promising antibodies to large scale manufacture requires careful planning. Cell culture considerations, media development, inoculum development and improvement, growth kinetics optimization and production technology choice can all impact quality and yield.
At Inotiv, we work with clients to clean, clone, and optimize promising cell lines before scaling them up to deliver production quantities of consistent antibodies.
Today, Inotiv delivers:
- Monoclonal and polyclonal antibody production
- Hybridoma development
- Immunogenicity immunization
- Antibody purification
- Mouse antibody production (MAP) testing
History, Strategies & Challenges
Download the Infographic Series
Get the fourth in a series of infographics, charting the history, production strategies, and technology challenges faced when producing antibodies for research and manufacture. These resources provide insights collated from our long history in antibody production, with quick reference production strategies and useful reminders of the challenges commonly faced by researchers and production engineers.
